Skip to main content
Erschienen in: Pathology & Oncology Research 2/2019

13.12.2018 | Original Article

Early Hereditary Diffuse Gastric Cancer (eHDGC) is Characterized by Subtle Genomic Instability and Active DNA Damage Response

verfasst von: Soroush Nasri, Bostjan Humara, Ahmad Anjomshoaa, Nourodin Moradi, Naghmeh Gholipour, Sakineh Mashjoor, Peng Zhang

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Diffuse gastric cancer (DGC) is one of the two primary types of stomach cancer. Carriers of germline mutations in the gene encoding E-cadherin are predisposed to DGC. The primary aim of the present study was to determine if genomic instability is an early event in DGC and how it may lead to disease progression. Chromosomal aberrations in early intramucosal hereditary diffuse gastric cancer (eHDGC) were assessed using array comparative genomic hybridization (array CGH). Notably, no aneuploidy or other large-scale chromosomal rearrangements were detected. Instead, all aberrations affected small regions (< 4.8 Mb) and were predominantly deletions. Analysis of DNA sequence patterns revealed that essentially all aberrations possessed the characteristics of common fragile sites. These results and the results of subsequent immunohistochemical examinations demonstrated that unlike advanced DGC, eHDGCs is characterized by low levels of genomic instability at fragile sites. Furthermore, they express an active DNA damage response, providing a molecular basis for the observed indolence of eHDGC. This finding is an important step to understanding the pathology underlying natural history of DGC and supports a revision of the current definition of eHDGC as a malignant disease.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMed
3.
Zurück zum Zitat Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49CrossRefPubMed Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49CrossRefPubMed
4.
Zurück zum Zitat Ekstrom AM, Hansson LE, Signorello LB, Lindgren A, Bergstrom R, Nyren O (2000) Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma-a population-based study in Sweden. Br J Cancer 83:391–396CrossRefPubMedPubMedCentral Ekstrom AM, Hansson LE, Signorello LB, Lindgren A, Bergstrom R, Nyren O (2000) Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma-a population-based study in Sweden. Br J Cancer 83:391–396CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J (2004) Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. Arch Pathol Lab Med 128:765–770PubMed Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J (2004) Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. Arch Pathol Lab Med 128:765–770PubMed
6.
Zurück zum Zitat Kattan MW, Karpeh MS, Mazumdar M, Brennan MF (2003) Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 21:3647–3650CrossRefPubMed Kattan MW, Karpeh MS, Mazumdar M, Brennan MF (2003) Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 21:3647–3650CrossRefPubMed
7.
Zurück zum Zitat Stone J, Bevan S, Cunningham D, Hill A, Rahman N, Peto J, Marossy A, Houlston RS (1999) Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer. Br J Cancer 79:1935–1937CrossRefPubMedPubMedCentral Stone J, Bevan S, Cunningham D, Hill A, Rahman N, Peto J, Marossy A, Houlston RS (1999) Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer. Br J Cancer 79:1935–1937CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392:402–405CrossRefPubMed Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392:402–405CrossRefPubMed
9.
Zurück zum Zitat Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Höfler H (1994) E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54:3845–3852PubMed Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Höfler H (1994) E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54:3845–3852PubMed
10.
Zurück zum Zitat Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ (2000) E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92:569–573CrossRefPubMed Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ (2000) E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92:569–573CrossRefPubMed
11.
Zurück zum Zitat Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simöes M (2001) E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20:1525–1528CrossRefPubMed Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simöes M (2001) E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20:1525–1528CrossRefPubMed
12.
Zurück zum Zitat Blair V, Martin I, Shaw D, Winship I, Kerr D, Arnold J, Harawira P, McLeod M, Parry S, Charlton A, Findlay M, Cox B, Humar B, More H, Guilford P (2006) Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol 4:262–275CrossRefPubMed Blair V, Martin I, Shaw D, Winship I, Kerr D, Arnold J, Harawira P, McLeod M, Parry S, Charlton A, Findlay M, Cox B, Humar B, More H, Guilford P (2006) Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol 4:262–275CrossRefPubMed
13.
Zurück zum Zitat Humar B, Fukuzawa R, Blair V, Dunbier A, More H, Charlton A, , Kim WH, Reeve AE, Martin I, Guilford P (2007) Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer. Cancer Res 67: 2480–2489CrossRefPubMed Humar B, Fukuzawa R, Blair V, Dunbier A, More H, Charlton A, , Kim WH, Reeve AE, Martin I, Guilford P (2007) Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer. Cancer Res 67: 2480–2489CrossRefPubMed
14.
Zurück zum Zitat Le Borgne R, Bellaiche Y, Schweisguth F (2002) Drosophila E-cadherin regulates the orientation of asymmetric cell division in the sensory organ lineage. Curr Biol 12:95–104CrossRefPubMed Le Borgne R, Bellaiche Y, Schweisguth F (2002) Drosophila E-cadherin regulates the orientation of asymmetric cell division in the sensory organ lineage. Curr Biol 12:95–104CrossRefPubMed
15.
Zurück zum Zitat Schluter MA, Pfarr CS, Pieczynski J, Whiteman EL, Hurd TW, Fan S, Liu CJ, Margolis B (2009) Trafficking of Crumbs3 during cytokinesis is crucial for lumen formation. Mol Biol Cell 20(22):4652–4663CrossRefPubMedPubMedCentral Schluter MA, Pfarr CS, Pieczynski J, Whiteman EL, Hurd TW, Fan S, Liu CJ, Margolis B (2009) Trafficking of Crumbs3 during cytokinesis is crucial for lumen formation. Mol Biol Cell 20(22):4652–4663CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Stehbens SJ, Akhmanova A, Yap AS (2009) Microtubules and cadherins: aneglected partnership. Front Biosci 14:3159–3167CrossRef Stehbens SJ, Akhmanova A, Yap AS (2009) Microtubules and cadherins: aneglected partnership. Front Biosci 14:3159–3167CrossRef
17.
Zurück zum Zitat Nasri S, Anjomshoaa A, Song S, Guilford P, McNoe L, Black M, Phillips V, Reeve A, Humar B (2010) Oligonucleotide array outperforms SNP array on formalin-fixed paraffin-embedded clinical samples. Cancer Genet Cytogenet 198(1):1–6CrossRefPubMed Nasri S, Anjomshoaa A, Song S, Guilford P, McNoe L, Black M, Phillips V, Reeve A, Humar B (2010) Oligonucleotide array outperforms SNP array on formalin-fixed paraffin-embedded clinical samples. Cancer Genet Cytogenet 198(1):1–6CrossRefPubMed
18.
Zurück zum Zitat Cleveland WS (1979) Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 74(368):829–836CrossRef Cleveland WS (1979) Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 74(368):829–836CrossRef
19.
Zurück zum Zitat van Dijk MC, Rombout PD, Boots-Sprenger SH, Straatman H, Bernsen MR, Ruiter DJ, Jeuken JW (2005) Multiplex ligation-dependent probe amplification for the detection of chromosomal gains and losses in formalin-fixed tissue. Diagn Mol Pathol 14(1):9–16CrossRefPubMed van Dijk MC, Rombout PD, Boots-Sprenger SH, Straatman H, Bernsen MR, Ruiter DJ, Jeuken JW (2005) Multiplex ligation-dependent probe amplification for the detection of chromosomal gains and losses in formalin-fixed tissue. Diagn Mol Pathol 14(1):9–16CrossRefPubMed
20.
Zurück zum Zitat Sarai A, Mazur J, Nussinov R, Jernigan RL (1989) Sequence dependence of DNA conformational flexibility. Biochem 28(19):7842–7849CrossRef Sarai A, Mazur J, Nussinov R, Jernigan RL (1989) Sequence dependence of DNA conformational flexibility. Biochem 28(19):7842–7849CrossRef
21.
Zurück zum Zitat Mishmar D, Rahat A, Scherer SW, Nyakatura G, Hinzmann B, Kohwi Y, Mandel-Gutfroind Y, Lee JR, Drescher B, Sas DE, Margalit H (1998) Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc Natl Acad Sci U S A 95:8141–8146CrossRefPubMedPubMedCentral Mishmar D, Rahat A, Scherer SW, Nyakatura G, Hinzmann B, Kohwi Y, Mandel-Gutfroind Y, Lee JR, Drescher B, Sas DE, Margalit H (1998) Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc Natl Acad Sci U S A 95:8141–8146CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Humar B, Guilford P (2009) Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci 100(7):1151–1157CrossRefPubMed Humar B, Guilford P (2009) Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci 100(7):1151–1157CrossRefPubMed
23.
Zurück zum Zitat Mimata A, Fukamachi H, Eishi Y, Yuasa Y (2011) Loss of E-cadherin in mouse gastric epithelial cells induces signet ring-like cells, a possible precursor lesion of diffuse gastric cancer. Cancer Sci 102(5):942–950CrossRefPubMed Mimata A, Fukamachi H, Eishi Y, Yuasa Y (2011) Loss of E-cadherin in mouse gastric epithelial cells induces signet ring-like cells, a possible precursor lesion of diffuse gastric cancer. Cancer Sci 102(5):942–950CrossRefPubMed
24.
Zurück zum Zitat Thoma CR, Toso A, Gutbrodt KL, Reggi SP, Frew IJ, Schraml P, Hergovich A, Moch H, Meraldi P, Krek W (2009) VHL loss causes spindle misorientation and chromosome instability. Nature Cell Biol 11(8):994–1001CrossRefPubMed Thoma CR, Toso A, Gutbrodt KL, Reggi SP, Frew IJ, Schraml P, Hergovich A, Moch H, Meraldi P, Krek W (2009) VHL loss causes spindle misorientation and chromosome instability. Nature Cell Biol 11(8):994–1001CrossRefPubMed
25.
Zurück zum Zitat Little SE, Vuononvirta R, Reis-Filho JS, Natrajan R, Iravani M, Fenwick K, Mackay A, Ashworth A, Pritchard-Jones K, Jones C (2006) Array CGH using whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNA. Genomics 87(2):298–306CrossRefPubMed Little SE, Vuononvirta R, Reis-Filho JS, Natrajan R, Iravani M, Fenwick K, Mackay A, Ashworth A, Pritchard-Jones K, Jones C (2006) Array CGH using whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNA. Genomics 87(2):298–306CrossRefPubMed
26.
Zurück zum Zitat Mc Sherry EA, Mc Goldrick A, Kay EW, Hopkins AM, Gallagher WM, Dervan PA (2007) Formalin-fixed paraffin-embedded clinical tissues show spurious copy number changes in array-CGH profiles. Clin Genet 72(5):441–447CrossRefPubMed Mc Sherry EA, Mc Goldrick A, Kay EW, Hopkins AM, Gallagher WM, Dervan PA (2007) Formalin-fixed paraffin-embedded clinical tissues show spurious copy number changes in array-CGH profiles. Clin Genet 72(5):441–447CrossRefPubMed
27.
Zurück zum Zitat Talseth-Palmer BA, Bowden NA, Hill A, Meldrum C, Scott RJ (2008) Whole genome amplification and its impact on CGH array profiles. BMC Res Notes 1(1):56CrossRefPubMedPubMedCentral Talseth-Palmer BA, Bowden NA, Hill A, Meldrum C, Scott RJ (2008) Whole genome amplification and its impact on CGH array profiles. BMC Res Notes 1(1):56CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat De Smith AJ, Tsalenko A, Sampas N, Scheffer A, Yamada NA, Tsang P, Ben-Dor A, Yakhini Z, Ellis RJ, Bruhn L, Laderman S (2007) Array CGH analysis of copy number variation identifies 1284 new genes variant in healthy white males: implications for association studies of complex diseases. Hum Mol Genet 16(23):2783–2794CrossRefPubMed De Smith AJ, Tsalenko A, Sampas N, Scheffer A, Yamada NA, Tsang P, Ben-Dor A, Yakhini Z, Ellis RJ, Bruhn L, Laderman S (2007) Array CGH analysis of copy number variation identifies 1284 new genes variant in healthy white males: implications for association studies of complex diseases. Hum Mol Genet 16(23):2783–2794CrossRefPubMed
29.
Zurück zum Zitat Brunet A, Armengol L, Heine D, Rosell J, García-Aragonés M, Gabau E, Estivill X, Guitart M (2009) BAC array CGH in patients with Velocardiofacial syndrome-like features reveals genomic aberrations on chromosome region 1q21. 1. BMC Med Genet 10(1):144CrossRefPubMedPubMedCentral Brunet A, Armengol L, Heine D, Rosell J, García-Aragonés M, Gabau E, Estivill X, Guitart M (2009) BAC array CGH in patients with Velocardiofacial syndrome-like features reveals genomic aberrations on chromosome region 1q21. 1. BMC Med Genet 10(1):144CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Ambros IM, Brunner B, Aigner G, Bedwell C, Beiske K, Bénard J, Bown N, Combaret V, Couturier J, Defferrari R, Gross N (2011) A multilocus technique for risk evaluation of patients with neuroblastoma. Clin Cancer Res 17(4):792–804CrossRefPubMed Ambros IM, Brunner B, Aigner G, Bedwell C, Beiske K, Bénard J, Bown N, Combaret V, Couturier J, Defferrari R, Gross N (2011) A multilocus technique for risk evaluation of patients with neuroblastoma. Clin Cancer Res 17(4):792–804CrossRefPubMed
31.
Zurück zum Zitat Shen Y, Wu BL (2009) Microarray-based genomic DNA profiling technologies in clinical molecular diagnostics. Clin Chem 55(4):659–669CrossRefPubMed Shen Y, Wu BL (2009) Microarray-based genomic DNA profiling technologies in clinical molecular diagnostics. Clin Chem 55(4):659–669CrossRefPubMed
32.
Zurück zum Zitat Hills A, Ahn JW, Donaghue C, Thomas H, Mann K, Ogilvie CM (2010) MLPA for confirmation of array CGH results and determination of inheritance. Mol Cytogen 3(1):19CrossRef Hills A, Ahn JW, Donaghue C, Thomas H, Mann K, Ogilvie CM (2010) MLPA for confirmation of array CGH results and determination of inheritance. Mol Cytogen 3(1):19CrossRef
33.
Zurück zum Zitat Cook JG (2009) Replication licensing and the DNA damage checkpoint. Front Biosci (Landmark edition) 14:5013CrossRef Cook JG (2009) Replication licensing and the DNA damage checkpoint. Front Biosci (Landmark edition) 14:5013CrossRef
34.
Zurück zum Zitat Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421(6922):499–506CrossRefPubMed Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421(6922):499–506CrossRefPubMed
35.
Zurück zum Zitat Abraham RT (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 15(17):2177–2196CrossRefPubMed Abraham RT (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 15(17):2177–2196CrossRefPubMed
37.
Zurück zum Zitat Casper AM, Durkin SG, Arlt MF, Glover TW (2004) Chromosomal instability at common fragile sites in Seckel syndrome. Am J Hum Genet 75(4):654–660CrossRefPubMedPubMedCentral Casper AM, Durkin SG, Arlt MF, Glover TW (2004) Chromosomal instability at common fragile sites in Seckel syndrome. Am J Hum Genet 75(4):654–660CrossRefPubMedPubMedCentral
38.
39.
Zurück zum Zitat Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674CrossRefPubMed Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674CrossRefPubMed
Metadaten
Titel
Early Hereditary Diffuse Gastric Cancer (eHDGC) is Characterized by Subtle Genomic Instability and Active DNA Damage Response
verfasst von
Soroush Nasri
Bostjan Humara
Ahmad Anjomshoaa
Nourodin Moradi
Naghmeh Gholipour
Sakineh Mashjoor
Peng Zhang
Publikationsdatum
13.12.2018
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 2/2019
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-018-0547-9

Weitere Artikel der Ausgabe 2/2019

Pathology & Oncology Research 2/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.